Search filters

List of works by Massimo Gentile

A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemia

scientific article published in April 2005

A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma

scientific article published on 18 February 2020

An old drug with a new future: bendamustine in multiple myeloma.

scientific article

Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia

scientific article published on 10 April 2015

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study.

scientific article published on 21 July 2016

CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL.

scientific article

Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia.

scientific article published on 9 October 2012

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

scientific article published on 13 August 2020

Clinical characteristics and treatment outcomes in IgE multiple myeloma: A case-control study.

scientific article

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.

scientific article

Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases.

scientific article published on 3 November 2017

Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases

scientific article published on 30 December 2020

Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients

scientific article published on 19 April 2020

Epigenetic regulation in myelodysplastic syndromes: implications for therapy

scientific article published on 08 March 2011

Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques

scientific article published on 25 June 2015

Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients

scientific article published on 13 August 2019

Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases

scientific article published on 30 July 2018

Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection

scientific article published on 13 December 2019

Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases

scientific article published on 11 July 2014

Janus kinase 2 inhibitors in myeloproliferative disorders

scientific article published on 04 December 2010

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

scientific article published on 14 August 2015

Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment

scientific article published on 24 July 2018

Primary refractory multiple myeloma: a real-world experience with 85 cases

scientific article published on 05 July 2020

Promising therapies for the treatment of chronic lymphocytic leukemia

scientific article

Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study

scientific article published on 31 March 2015

Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia

scientific article

Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL)

scientific article published on 17 June 2020

Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study

scientific article published in August 2017

Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment

scientific article published on 19 May 2015

Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study

scientific article published on 14 April 2020

The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.

scientific article published in August 2005

Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study

scientific article published on 12 June 2013

Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab

scientific article published on 20 March 2018

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab

scientific article published on 16 September 2020

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients.

scientific article published on 22 August 2016

Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL).

scientific article published on November 2011

Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies

scientific article published on 11 August 2020